Aequus Net Tangible Assets vs Other Current Liab Analysis

AQS Stock  CAD 0.01  0.01  100.00%   
Aequus Pharmaceuticals financial indicator trend analysis is way more than just evaluating Aequus Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aequus Pharmaceuticals is a good investment. Please check the relationship between Aequus Pharmaceuticals Net Tangible Assets and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aequus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Tangible Assets vs Other Current Liab

Net Tangible Assets vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aequus Pharmaceuticals Net Tangible Assets account and Other Current Liab. At this time, the significance of the direction appears to have very week relationship.
The correlation between Aequus Pharmaceuticals' Net Tangible Assets and Other Current Liab is 0.26. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Aequus Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Aequus Pharmaceuticals' Net Tangible Assets and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Aequus Pharmaceuticals are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Net Tangible Assets i.e., Aequus Pharmaceuticals' Net Tangible Assets and Other Current Liab go up and down completely randomly.

Correlation Coefficient

0.26
Relationship DirectionPositive 
Relationship StrengthVery Weak

Net Tangible Assets

The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.

Other Current Liab

Most indicators from Aequus Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aequus Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aequus Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Aequus Pharmaceuticals' Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 8.81 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (3.21) in 2024.
 2021 2022 2023 2024 (projected)
Reconciled Depreciation128.1K129.8K138.2K147.6K
Interest Income13.2K24.7K4.1K3.9K

Aequus Pharmaceuticals fundamental ratios Correlations

0.050.510.49-0.01-0.36-0.340.420.840.410.840.680.350.240.560.690.10.940.420.19-0.010.290.32-0.19-0.250.42
0.05-0.760.50.770.78-0.730.05-0.120.36-0.11-0.10.690.720.31-0.360.92-0.070.590.480.16-0.48-0.5-0.65-0.55-0.63
0.51-0.760.02-0.79-0.940.530.280.6-0.040.580.33-0.49-0.530.010.56-0.80.56-0.38-0.56-0.170.450.460.620.490.84
0.490.50.020.22-0.06-0.280.130.550.070.570.010.350.220.42-0.220.330.510.24-0.070.26-0.3-0.35-0.18-0.14-0.08
-0.010.77-0.790.220.77-0.84-0.23-0.240.28-0.230.130.80.690.5-0.220.91-0.10.730.820.51-0.34-0.33-0.88-0.78-0.75
-0.360.78-0.94-0.060.77-0.67-0.26-0.560.2-0.55-0.080.590.650.08-0.30.85-0.460.540.64-0.01-0.31-0.33-0.67-0.62-0.75
-0.34-0.730.53-0.28-0.84-0.670.050.08-0.60.07-0.51-0.94-0.79-0.7-0.2-0.85-0.16-0.97-0.77-0.280.10.150.790.890.53
0.420.050.280.13-0.23-0.260.050.340.550.34-0.12-0.17-0.070.110.17-0.030.25-0.05-0.24-0.22-0.12-0.130.340.280.06
0.84-0.120.60.55-0.24-0.560.080.34-0.091.00.33-0.03-0.10.180.43-0.110.95-0.04-0.03-0.130.250.330.00.080.53
0.410.36-0.040.070.280.2-0.60.55-0.09-0.090.360.490.460.630.350.330.080.640.170.13-0.19-0.27-0.1-0.3-0.18
0.84-0.110.580.57-0.23-0.550.070.341.0-0.090.33-0.02-0.090.190.42-0.10.95-0.03-0.03-0.130.240.32-0.010.070.52
0.68-0.10.330.010.13-0.08-0.51-0.120.330.360.330.510.370.550.870.080.610.630.440.030.640.62-0.39-0.610.31
0.350.69-0.490.350.80.59-0.94-0.17-0.030.49-0.020.510.790.630.150.780.20.960.70.38-0.1-0.13-0.8-0.84-0.42
0.240.72-0.530.220.690.65-0.79-0.07-0.10.46-0.090.370.790.460.090.780.10.750.620.22-0.12-0.1-0.76-0.7-0.26
0.560.310.010.420.50.08-0.70.110.180.630.190.550.630.460.30.380.390.710.350.54-0.11-0.18-0.36-0.54-0.16
0.69-0.360.56-0.22-0.22-0.3-0.20.170.430.350.420.870.150.090.3-0.180.620.340.24-0.310.680.7-0.06-0.260.53
0.10.92-0.80.330.910.85-0.85-0.03-0.110.33-0.10.080.780.780.38-0.180.00.720.770.18-0.33-0.32-0.84-0.74-0.68
0.94-0.070.560.51-0.1-0.46-0.160.250.950.080.950.610.20.10.390.620.00.230.15-0.060.370.44-0.18-0.170.51
0.420.59-0.380.240.730.54-0.97-0.05-0.040.64-0.030.630.960.750.710.340.720.230.710.28-0.01-0.06-0.71-0.85-0.39
0.190.48-0.56-0.070.820.64-0.77-0.24-0.030.17-0.030.440.70.620.350.240.770.150.710.170.090.17-0.92-0.83-0.46
-0.010.16-0.170.260.51-0.01-0.28-0.22-0.130.13-0.130.030.380.220.54-0.310.18-0.060.280.17-0.29-0.31-0.32-0.25-0.28
0.29-0.480.45-0.3-0.34-0.310.1-0.120.25-0.190.240.64-0.1-0.12-0.110.68-0.330.37-0.010.09-0.290.97-0.04-0.270.44
0.32-0.50.46-0.35-0.33-0.330.15-0.130.33-0.270.320.62-0.13-0.1-0.180.7-0.320.44-0.060.17-0.310.97-0.09-0.210.52
-0.19-0.650.62-0.18-0.88-0.670.790.340.0-0.1-0.01-0.39-0.8-0.76-0.36-0.06-0.84-0.18-0.71-0.92-0.32-0.04-0.090.870.46
-0.25-0.550.49-0.14-0.78-0.620.890.280.08-0.30.07-0.61-0.84-0.7-0.54-0.26-0.74-0.17-0.85-0.83-0.25-0.27-0.210.870.47
0.42-0.630.84-0.08-0.75-0.750.530.060.53-0.180.520.31-0.42-0.26-0.160.53-0.680.51-0.39-0.46-0.280.440.520.460.47
Click cells to compare fundamentals

Aequus Pharmaceuticals Account Relationship Matchups

Aequus Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.7M3.1M4.3M1.7M1.1M1.0M
Total Current Liabilities476.0K384.3K2.5M2.4M4.8M5.0M
Total Stockholder Equity(877.1K)574.0K1.8M(1.4M)(4.3M)(4.1M)
Net Tangible Assets934.2K(961.9K)574.0K1.8M1.6M1.7M
Property Plant And Equipment Net480.1K366.3K242.3K788.8K650.6K683.1K
Net Debt1.7M604.7K(211.3K)533.1K4.9M5.1M
Retained Earnings(23.7M)(24.7M)(26.5M)(29.7M)(32.7M)(31.1M)
Accounts Payable249.5K160.9K157.1K88.5K274.2K286.1K
Cash484.5K1.7M2.4M249.8K170.2K161.7K
Non Current Assets Total564.9K366.3K755.1K788.8K650.6K710.7K
Cash And Short Term Investments484.5K1.7M2.4M294.7K215.0K204.3K
Net Receivables556.3K779.5K941.1K310.1K31.7K30.1K
Common Stock Shares Outstanding80.4M93.2M128.8M132.6M152.5M83.9M
Liabilities And Stockholders Equity1.7M3.1M4.3M1.7M1.1M1.0M
Inventory5.4K123.3K139.8K93.8K123.7K129.9K
Other Current Assets61.5K146.7K120.5K204.1K65.1K113.5K
Other Stockholder Equity3.7M4.1M4.3M(1.0)(1.15)(1.09)
Total Liab2.5M2.6M2.6M3.1M5.4M5.6M
Total Current Assets1.1M2.8M3.6M902.7K435.6K413.8K
Common Stock18.9M19.1M21.2M24.0M27.6M17.2M
Property Plant Equipment14.1K480.1K366.3K242.3K278.6K292.6K
Other Current Liab83K76.3K221.7K2.2M42.1K40.0K
Non Currrent Assets Other19.0K761.5K512.8K(1.0)(1.15)(1.09)
Non Current Liabilities Total2.1M2.2M102.0K693.8K583.6K774.1K
Net Invested Capital888.3K2.6M3.7M620.0K76.2K72.3K
Net Working Capital631.7K2.4M1.1M(1.5M)(4.4M)(4.1M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aequus Stock Analysis

When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.